1.0800
+0.0400
+(3.85%)
As of January 23 at 4:00:00 PM EST. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| COLLINS COOPER C Director | Purchase | Aug 22, 2024 | 52,016 |
| DONEGAN MICHAEL C Chief Financial Officer | Conversion of Exercise of derivative security | Apr 12, 2023 | 61,853 |
| RUBRIC CAPITAL MANAGEMENT L.P. Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Nov 15, 2023 | -- |
| WALKER MARLAN D Chief Executive Officer | Sale | Dec 7, 2023 | 62,565 |
| ZIEGLER JOSEPH Chief Financial Officer | Stock Award(Grant) | Aug 17, 2023 | 7,500 |
Related Tickers
ANIK Anika Therapeutics, Inc.
16.37
+0.92%
CPHI China Pharma Holdings, Inc.
0.1825
-13.05%
YCBD cbdMD, Inc.
0.6290
+4.83%
KNSA Kiniksa Pharmaceuticals International, plc
19.77
+2.92%
SXTC China SXT Pharmaceuticals, Inc.
0.3910
-5.19%
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.9200
-6.22%
PTLF Petlife Pharmaceuticals, Inc.
0.0001
0.00%
LWA.F ECO Animal Health Group plc
0.7350
0.00%
ER4.SG Emergent BioSolutions Inc
10.74
-1.69%
KHTRF Knight Therapeutics Inc.
3.8800
0.00%